Last $1.57 USD
Change Today +0.10 / 6.80%
Volume 78.1K
OCLS On Other Exchanges
Symbol
Exchange
OCLS is not on other exchanges.
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

oculus innovative sciences i (OCLS) Key Developments

Oculus Innovative Sciences, Inc. Approves Amendment to Restated Certificate of Incorporation

The Special Meeting of Stockholders of Oculus Innovative Sciences, Inc. was held on December 4, 2014. At the Special Meeting, the company's stockholders were asked to approve an amendment to the company's Restated Certificate of Incorporation, as amended, to increase the number of authorized common stock, $0.0001 par value per share, to a total number of 30,000,000 shares.

Oculus Innovative Sciences, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Oculus Innovative Sciences, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported total revenues of $3,264,000 against $4,089,000 a year ago. Loss from operations was $1,544,000 against $1,271,000 a year ago. Net loss was $718,000 against $1,399,000 a year ago. Basic and diluted net loss per share was $0.08 against $0.21 a year ago. Non-GAAP loss from operations minus non-cash expenses (EBITDAS) was $1,051,000 against $882,000 a year ago. The increased revenue was due to the strong growth in the sales of hydrogel and 120-milliliter liquid products. The decrease in net loss from the prior year is due to the mark-to-market adjustment of derivative liabilities related to outstanding common stock purchase warrants. For the six months, the company reported total revenues of $6,656,000 against $7,461,000 a year ago. Loss from operations was $3,058,000 against $2,397,000 a year ago. Net loss was $788,000 against $3,111,000 a year ago. Basic and diluted net loss per share was $0.09 against $0.47 a year ago. Non-GAAP loss from operations minus non-cash expenses (EBITDAS) was $2,050,000 against $1,595,000 a year ago.

Oculus Innovative Sciences, Inc. Proposes Amendment to Certificate of Incorporation

Oculus Innovative Sciences, Inc. at the Special Meeting of Stockholders to be held on December 4, 2014, proposed an amendment to the company’s Restated Certificate of Incorporation, as amended, to increase the number of authorized common stock, $0.0001 par value per share, to a total number of 30,000,000 shares.

Oculus Innovative Sciences, Inc., Special/Extraordinary Shareholders Meeting, Dec 04, 2014

Oculus Innovative Sciences, Inc., Special/Extraordinary Shareholders Meeting, Dec 04, 2014., at 10:00 Pacific Standard Time. Location: 1129 N. McDowell Blvd. Agenda: To approve an amendment to the company’s restated Certificate of Incorporation, as amended, to increase the number of authorized common stock, $0.0001 par value per share, to a total number of 30,000,000 shares; and to transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.

Oculus Innovative Sciences, Inc. to Report Q2, 2015 Results on Nov 13, 2014

Oculus Innovative Sciences, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Nov 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCLS:US $1.57 USD +0.10

OCLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,703 JPY +47.50
Henry Schein Inc $137.51 USD +1.71
Integra LifeSciences Holdings Corp $52.92 USD +0.43
Patterson Cos Inc $49.03 USD +0.27
Smith & Nephew PLC 1,089 GBp +4.00
View Industry Companies
 

Industry Analysis

OCLS

Industry Average

Valuation OCLS Industry Range
Price/Earnings 2.0x
Price/Sales 1.0x
Price/Book 1.0x
Price/Cash Flow 2.2x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCULUS INNOVATIVE SCIENCES I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.